Upcoming COCA Call: November 29, 2016 - Assessment and Evidence-based Treatments for Opioid Use Disorder

Overview

One substantial risk associated with prescribing opioids for chronic pain is opioid use disorder (OUD). This disorder is associated with specific criteria, such as unsuccessful efforts to cut down or control opioid use, as well as use resulting in social problems and a failure to fulfill obligations at work, school, or home.

During this COCA Call, clinicians will learn about OUD diagnosis criteria, evidence-based treatment options, and patient education techniques. Presenters will use actual case studies to illustrate how clinicians can use recommendations from the CDC Guideline for Prescribing Opioids for Chronic Pain to select OUD evidence-based treatment options such as medication-assisted treatment with buprenorphine or methadone in combination with behavioral therapies.

Date: Tuesday, November 29, 2016

Time:  2:00 - 3:00 pm (Eastern Time)

Join by Phone:

800-779-0686 (U.S. Callers)
312-470-0194 (International Callers)

Passcode: 3377346

Join by Webinar

The recordings (audio, slides, and transcript) for this call will be posted on the webpage a few days after the COCA Call.

Follow these steps to earn free continuing education.

Objectives

  • Describe Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition (DSM-5) assessment criteria for opioid use disorder.
  • Discuss the evidence for opioid use disorder medication-assisted treatment.
  • List types of medications and settings used in medication-assisted therapy.
  • Review considerations for buprenorphine, methadone, and naltrexone use for opioid use disorder.
  • Outline the opioid taper process used when opioid harms exceed opioid benefits but opioid use disorder DSM-5 criteria are not met.

Presenter

Deborah Dowell, MD, MPH
Senior Medical Advisor
Division of Unintentional Injury Prevention
National Center for Injury Control and Prevention
Centers for Disease Control and Prevention

Joseph O. Merrill, MD, MPH
Associate Professor
Department of Medicine
University of Washington
Harborview Medical Center

Mark Sullivan, MD, PhD
Professor
Psychiatry and Behavioral Sciences
Anesthesiology and Pain Medicine
Bioethics and Humanities
University of Washington

Accreditation Statements:

CME: The Centers for Disease Control and Prevention is accredited by the Accreditation Council for Continuing Medical Education (ACCME®) to provide continuing medical education for physicians.

The Centers for Disease Control and Prevention designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should only claim credit commensurate with the extent of their participation in the activity.

CNE: The Centers for Disease Control and Prevention is accredited as a provider of Continuing Nursing Education by the American Nurses Credentialing Center's Commission on Accreditation.

This activity provides 1.0 contact hour.

IACET CEU: The Centers for Disease Control and Prevention is authorized by IACET to offer 1.0 CEU's for this program.

CECH: Sponsored by the Centers for Disease Control and Prevention, a designated provider of continuing education contact hours (CECH) in health education by the National Commission for Health Education Credentialing, Inc. This program is designed for Certified Health Education Specialists (CHES) and/or Master Certified Health Education Specialists (MCHES) to receive up to 1.0 total Category I continuing education contact hours. Maximum advanced level continuing education contact hours available are 0. CDC provider number 98614.

CPE: The Centers for Disease Control and Prevention is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. This program is a designated event for pharmacists to receive 0.1 CEUs in pharmacy education. The Universal Activity Number is 0387-0000-16-210-L04-P and enduring 0387-0000-16-210-H04-P course category.

Course Category: This activity has been designated as knowledge-based.

Once credit is claimed, an unofficial statement of credit is immediately available on TCEOnline. Official credit will be uploaded within 60 days on the NABP/CPE Monitor.

AAVSB/RACE: This program was reviewed and approved by the AAVSB RACE program for 1.0 hours of continuing education in the jurisdictions which recognize AAVSB RACE approval. Please contact the AAVSB RACE Program at race@aavsb.org if you have any comments/concerns regarding this program’s validity or relevancy to the veterinary profession.

CPH: The Centers for Disease Control and Prevention is a pre-approved provider of Certified in Public Health (CPH) recertification credits and is authorized to offer 1 CPH recertification credit for this program.

CDC is an approved provider of CPH Recertification Credits by the National Board of Public Health Examiners. Effective October 1, 2013, the National Board of Public Health Examiners (NBPHE) accepts continuing education units (CEU) for CPH recertification credits from CDC. Please select CEU as your choice for continuing education when registering for a course on TCEOnline. Learners seeking CPH should use the guidelines provided by the NBPHE for calculating recertification credits. For assistance please contact NBPHE at http://www.NBPHE.org.

There is no cost for this program.

DISCLOSURE: In compliance with continuing education requirements, CDC, our planners, our presenters, and their spouses/partners wish to disclose they have no financial interests or other relationships with the manufacturers of commercial products, suppliers of commercial services, or commercial supporters. Planners have reviewed content to ensure there is no bias.

The presentation will not include any discussion of the unlabeled use of a product or a product under investigational use.
CDC does not accept commercial support.

Recent Stories
Compensation and benefits survey report for occupational health nursing now available

Free Continuing Education Opportunity in Infection Prevention and Control

Hear from a member of the AAOHN Hepatitis C project team!